1 Dividend Stock Down 30% to Buy and Hold for the Next Decade
Biotech giant Regeneron Pharmaceuticals (REGN) saw its fortunes reversed last year. Though the drugmaker had performed well since the beginning of the decade, it encountered issues that sank its stock…